Tag Archives: Takeda

From Cyprus to Cambridge: The Rise of Anna Protopapas, Millennium Takeda's New President

Takeda’s Oncology Taskmaster Millennium Takeda’s new president, Anna Protopapas, explains to Pharm exec’s William Looney the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease. PE: The ascent to the “c suite” is not exclusively the result of hard work. Culture, […]
Posted in Global, Strategy | Also tagged , , , | Leave a comment

Frontrunners in Innovation: New Drug Approvals 2013

Frontrunners in Innovation: New Drug Approvals 2013 Trying to nail down the actual number of new drugs approvals in 2013 is like trying to swat a fly—it can be highly illusive.  Safe to say, however, as 2013 drew to a close,  the total number of new did not match 2012’s  high of 39. And yet, […]
Posted in Regulatory | Also tagged , , , , , | Leave a comment

New York Pharma Forum: Together We Stand

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Posted in Biotech, Events, leadership, People, R&D, Strategy, Technology | Also tagged , , , , , , , , , , | Leave a comment

Takeda Launches New Plan, Cuts US Jobs

Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.” The punch line, however, isn’t too funny. According to a two-year mid-range plan announced yesterday, Takeda will cut about 1,400 positions in the US […]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

Avandia Trial in Trouble

GSK’s Avandia just won’t stay out of the news. Now comes a report from The Wall Street Journal that the FDA is considering dealing the beleaguered diabetes drug another blow by stopping one of its safety trials. The TIDE trial, which received approval in 2007, pits Avandia (rosiglitazone) against Takeda’s Actos (pioglitazone), a drug that […]
Posted in Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta